多烯磷脂酰胆碱在裸鼠模型中逆转胃癌细胞奥沙利铂耐药的作用及机制研究

doi:10.11904/j.issn.1002-3070.2018.05.001

摘要/Abstract

摘要： 目的探讨多烯磷脂酰胆碱(PPC)在裸鼠模型中对人胃腺癌耐奥沙利铂细胞株(SGC-7901/L-OHP)的逆转耐药的作用及其机制。方法用继发性耐药细胞株SGC-7901/L-OHP建立裸鼠皮下移植瘤模型,并随机分为4组,空白对照组、多烯磷脂酰胆碱(PPC)组、奥沙利铂(L-OHP)组及奥沙利铂联合多烯磷脂酰胆碱(L-OHP+PPC)组,连续给药14天。21天后处死裸鼠,剥离肿瘤组织,记录肿瘤体积和抑瘤率,对切除的肿瘤组织分别提取肿瘤组织的RNA和蛋白,采用实时荧光定量PCR(qRT-PCR)及Western blot检测TLR4、Nanog及ABCF2表达水平。结果加药处理后,与空白对照组相比,L-OHP组及L-OHP+PPC组移植瘤细胞的增殖均受到抑制(P＜0.001),两药联合有交互作用(P=0.008);L-OHP+PPC组的体积抑瘤率高于空白对照组(P＜0.001)及L-OHP组(P＜0.001)。L-OHP+PPC组TLR4/Nanog/ABCF2的mRNA表达较空白对照组低,差异有统计学意义(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001);L-OHP+PPC组TLR4/Nanog/ABCF2的mRNA表达较L-OHP组低,差异有统计学意义(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001)。两药联合对TLR4/Nanog/ABCF2的mRNA表达均有交互作用,差异有统计学意义(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001)。L-OHP+PPC组TLR4/Nanog/ABCF2的蛋白表达较空白对照组低,差异有统计学意义(TLR4:P=0.006;Nanog:P=0.017;ABCF2:P=0.014);L-OHP+PPC组TLR4/Nanog/ABCF2的蛋白表达较L-OHP组低,差异有统计学意义(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001)。两药联合对TLR4/Nanog/ABCF2的蛋白表达均有交互作用,差异有统计学意义(TLR4:P=0.014;Nanog:P=0.01;ABCF2:P=0.015)。结论多烯磷脂酰胆碱在裸鼠模型中对人胃癌耐奥沙利铂细胞株(SGC-7901/L-OHP)有逆转耐药的作用,可能通过影响TLR4、Nanog、ABCF2表达逆转人胃癌耐药细胞的耐药作用。

关键词: 多烯磷脂酰胆碱, 奥沙利铂, 胃癌, 裸鼠模型

Abstract: Objective The Objective of this study was to investigate the effect of polyene phosphatidylcholine(PPC)on the reversal of resistance to human oxaliplatin-resistant cell lines(SGC-7901/L-OHP)in nude mice and its mechanism.Methods The subcutaneous xenograft model of nude mouse was established with a secondary drug-resistant SGC-7901/L-OHP cell line and randomly divided into four groups:blank control group,oxaliplatin group,PPC group and oxaliplatin combined with PPC group.The mice were administered continuously for 14 days.After 21 days,the nude mice were sacrificed and the tumor tissues were removed.The tumor volume and inhibitory rate of tumor were recorded.The RNA and protein of tumor tissue were extracted from the resected tumor tissue.Real-time quantitative PCR(qRT-PCR)and western blot were used to examine the expression of TLR4,Nanog and ABCF2.Results After treatment,the proliferation of transplanted tumor cells in L-OHP group and L-OHP+PPC group was inhibited compared with the blank control group,P value was <0.001,the two drugs combined interaction,P=0.008;The volume inhibition rate of the L-OHP+PPC group was higher than that of the blank control group(P＜0.001)and the L-OHP group(P＜0.001).The mRNA expression of TLR4/Nanog/ABCF2 in L-OHP+PPC group was significantly different from that in the control group(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001);The mRNA expression of TLR4/Nanog/ABCF2 in L-OHP+PPC group was significantly different from that of L-OHP group(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001).The combination of the two drugs had an interaction effect on the mRNA expression of TLR4/Nanog/ABCF2(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001).The protein expression of TLR4/Nanog/ABCF2 in L-OHP+PPC group was significantly different from that in the control group(TLR4:P=0.006;Nanog:P=0.017;ABCF2:P=0.014);The protein expression of TLR4/Nanog/ABCF2 in L-OHP+PPC group was significantly different from that of L-OHP group(TLR4:P＜0.001;Nanog:P＜0.001;ABCF2:P＜0.001).The combination of the two drugs had an interaction effect on the protein expression of TLR4/Nanog/ABCF2,and the difference was statistically significant(TLR4:P=0.014;Nanog:P=0.01;ABCF2:P=0.015).Conclusion PPC has a reversal resistance to human gastric cancer-resistant oxaliplatin(SGC-7901/L-OHP)cell line in nude mouse,possibly by reducing TLR4,Nanog,ABCF2 at the levels of mRNA and proteins to reverses the drug resistance of human gastric cancer resistant cells.

Key words: Polyene phosphatidylcholine, Oxaliplatin, Gastric cancer, Nude mouse model

中图分类号:

R73-34

伊庆亭, 张红军, 姜韬, 傅佳雷, 华明涛. 多烯磷脂酰胆碱在裸鼠模型中逆转胃癌细胞奥沙利铂耐药的作用及机制研究[J]. 实用肿瘤学杂志, 2018, 32(5): 385-390.

YI Qingting, ZHANG Hongjun, JIANG Tao, FU Jialei, HUA Mingtao. Reversal effect and mechanism of polyene phosphatidylcholine on oxaliplatin resistance of gastric cancer cells in a nude mouse model[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 385-390.

参考文献

1 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
2 徐瑞华,滕开原.晚期胃癌化疗进展[J].癌症,2009,28(10):1108-1113.
3 Jiang T,Zhang H,Liu X,et al.Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC-7901 cells[J].Oncol Lett,2016,12(6):4538-4546.
4 Gyémánt N,Engi H,Schelz Z,et al.In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin[J].Br J Cancer,2010,103(2):178-185.
5 Kovács T,Varga G,Erces D,et al.Dietary phosphatidylcholine supplementation attenuates inflammatory mucosal damage in a rat model of experimental colitis[J].Shock,2012,38(2):177-185.
6 Anderson KV,Bokla L,Nüsslein-Volhard C.Establishment of dorsal-ventral polarity in the Drosophila embryo:the induction of polarity by the Toll gene product[J].Cell,1985,42(3):791-798.
7 Matin N,Tabatabaie O,Falsaperla R,et al.Epilepsy and innate immune system:A possible immunogenic predisposition and related therapeutic implications[J].Hum Vaccin Immunother,2015,11(8):2021-2029.
8 Chiou SH,Wang ML,Chou YT,et al.Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation[J].Cancer Res,2010,70(24):10433-10444.
9 Zbinden M,Duquet A,Lorente-Trigos A,et al.NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53[J].EMBO J,2010,29(15):2659-2674.
10 Du Y,Ma C,Wang Z,et al.Nanog,a novel prognostic marker for lung cancer[J].Surg Oncol,2013,22(4):224-229.
11 Zhang J,Espinoza LA,Kinders RJ,et al.NANOG modulates stemness in human colorectal cancer[J].Oncogene,2013,32(37):4397-4405.
12 Fujii H,Honoki K,Tsujiuchi T,et al.Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines[J].Int J Oncol,2009,34(5):1381-1386.
13 Wang L,Park P,Lin CY.Characterization of stem cell attributes in human osteosarcoma cell lines[J].Cancer Biol Ther,2009,8(6):543-552.
14 Kerr ID.Sequence analysis of twin ATP binding cassette proteins involved in translational control,antibiotic resistance,and ribonuclease L inhibition[J].Biochem Biophys Res Commun,2004,315(1):166-173.
15 Liu X,Li S,Peng W,et al.Genome-wide identification,characterization and phylogenetic analysis of ATP-binding cassette(ABC)transporter genes in common carp(Cyprinus carpio)[J].PLoS One,2016,11(4):e0153246.
16 Yasui K,Mihara S,Zhao C,et al.Alteration in copy numbers of genes as a mechanism for acquired drug resistance[J].Cancer Res,2004,64(4):1403-1410.
17 高蕾,张红军,姜韬,等.多烯磷脂酰胆碱与奥沙利铂协同抗胃癌细胞增殖的研究[J].临床肿瘤学杂志,2015,20(12):1074-1079.

[1]	秦文,赵楠楠,韩永焕,徐亚君. ZNF436在胃癌中的表达及调控WNT/β-catenin对胃癌细胞迁移及侵袭的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 222-227.
[2]	孟海,杜观祥,朱利玲,汤琪云. WEE1在胃癌组织中的表达及对患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 239-243.
[3]	刘佳音,燕飞虎,张艳桥. 凋亡基因Caspase3和Caspase7单核苷酸多态性与胃癌遗传易感性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 250-255.
[4]	白玉贤, 马仲娟, 苏颖玲, 慕安国, 谢蕊. 胃癌患者FHIT、hMLH1、p16、RAR-beta、Reprimo和TIMP3基因的甲基化研究[J]. 实用肿瘤学杂志, 2019, 33(1): 8-13.
[5]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[6]	张宝综述, 郑志超校审. 进展期胃癌淋巴结清扫研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 78-81.
[7]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[8]	姚强, 王宽, 薛英威. SRC1在胃癌中的表达及其与预后的关系[J]. 实用肿瘤学杂志, 2018, 32(2): 97-102.
[9]	余嘉惠, 刘煊, 李琦, 陆烨, 岳小强. 长链非编码RNA在胃癌中的调控机制及中药对其作用的研究概况[J]. 实用肿瘤学杂志, 2018, 32(1): 47-52.
[10]	刘国慧, 谷安鑫, 殷洪涛, 曹阳, 贺云龙, 王春波, 鄂明艳. 原苏木素A对胃癌SGC-7901细胞系放疗增敏作用的研究[J]. 实用肿瘤学杂志, 2017, 31(6): 500-505.
[11]	张纯慧, 刘霞, 徐京京, 周艳华, 赵娟, 李志伟, 张艳桥. 633例胃癌患者临床病理特征及生存分析[J]. 实用肿瘤学杂志, 2017, 31(5): 396-404.
[12]	孙丽娜, 赵晓迪综述, 卢瑗瑗, 王新审校. LncRNA与胃肠道肿瘤化疗耐药的研究进展[J]. 实用肿瘤学杂志, 2017, 31(5): 448-453.
[13]	张锡,陈力,薛英威. 外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值[J]. 实用肿瘤学杂志, 2017, 31(4): 342-347.
[14]	董峰, 马君俊, 蔡正昊, 赵轩, 郑民华. 血清miR-21和miR-34a与晚期胃癌患者Folfox化疗方案化疗疗效的关系研究[J]. 实用肿瘤学杂志, 2017, 31(2): 147-151.
[15]	李恩就, 胡菂菂, 龚志军, 卿笃桔, 刘虹, 黎飞. 血清胃蛋白酶原联合Ca724在胃癌患者中的诊断及预后价值[J]. 实用肿瘤学杂志, 2017, 31(1): 18-22.